Terms: = Cervical cancer AND MYD88, Q99836, MYD88D, 4615
12 results:
1. Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.
Yoon J; Choi Y; Jang J; Shin NY; Ahn KJ; Kim BS
PLoS One; 2021; 16(12):e0261233. PubMed ID: 34898649
[TBL] [Abstract] [Full Text] [Related]
2. Immune Response of Plasmacytoid Dendritic Cells Stimulated by Human Papillomavirus (HPV) E6 in an In Vitro System.
Xu X; Yuan S; Zhang X; Lou H
Med Sci Monit; 2020 Feb; 26():e919770. PubMed ID: 32089541
[TBL] [Abstract] [Full Text] [Related]
3. The role of Toll-like receptor 4 signaling pathway in ovarian, cervical, and endometrial cancers.
Lupi LA; Cucielo MS; Silveira HS; Gaiotte LB; Cesário RC; Seiva FRF; de Almeida Chuffa LG
Life Sci; 2020 Apr; 247():117435. PubMed ID: 32081661
[TBL] [Abstract] [Full Text] [Related]
4. HPV-transformed cells exhibit altered HMGB1-TLR4/myd88-SARM1 signaling axis.
Morale MG; da Silva Abjaude W; Silva AM; Villa LL; Boccardo E
Sci Rep; 2018 Feb; 8(1):3476. PubMed ID: 29472602
[TBL] [Abstract] [Full Text] [Related]
5. Antitumor Activity of Portulaca Oleracea L. Polysaccharide on HeLa Cells Through Inducing TLR4/NF-κB Signaling.
Zhao R; Zhang T; Ma B; Li X
Nutr Cancer; 2017 Jan; 69(1):131-139. PubMed ID: 27911090
[TBL] [Abstract] [Full Text] [Related]
6. Risk of Human Papillomavirus (HPV) Infection and cervical Neoplasia after Pregnancy.
Trottier H; Mayrand MH; Baggio ML; Galan L; Ferenczy A; Villa LL; Franco EL;
BMC Pregnancy Childbirth; 2015 Oct; 15():244. PubMed ID: 26446835
[TBL] [Abstract] [Full Text] [Related]
7. TLR4-myd88-TRAF6-TAK1 Complex-Mediated NF-κB Activation Contribute to the Anti-Inflammatory Effect of V8 in LPS-Induced Human cervical cancer SiHa Cells.
He A; Ji R; Shao J; He C; Jin M; Xu Y
Inflammation; 2016 Feb; 39(1):172-181. PubMed ID: 26276130
[TBL] [Abstract] [Full Text] [Related]
8. Normal and cancer stem cells of the human female reproductive system.
López J; Valdez-Morales FJ; Benítez-Bribiesca L; Cerbón M; Carrancá AG
Reprod Biol Endocrinol; 2013 Jun; 11():53. PubMed ID: 23782518
[TBL] [Abstract] [Full Text] [Related]
9. Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.
Alphs HH; Gambhira R; Karanam B; Roberts JN; Jagu S; Schiller JT; Zeng W; Jackson DC; Roden RB
Proc Natl Acad Sci U S A; 2008 Apr; 105(15):5850-5. PubMed ID: 18413606
[TBL] [Abstract] [Full Text] [Related]
10. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells.
Fichorova RN; Trifonova RT; Gilbert RO; Costello CE; Hayes GR; Lucas JJ; Singh BN
Infect Immun; 2006 Oct; 74(10):5773-9. PubMed ID: 16988255
[TBL] [Abstract] [Full Text] [Related]
11. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract] [Full Text] [Related]
12. Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.
Senchenko V; Liu J; Braga E; Mazurenko N; Loginov W; Seryogin Y; Bazov I; Protopopov A; Kisseljov FL; Kashuba V; Lerman MI; Klein G; Zabarovsky ER
Oncogene; 2003 May; 22(19):2984-92. PubMed ID: 12771950
[TBL] [Abstract] [Full Text] [Related]
